Return to top 50 pharma list

Summary

Website: Cephalon

Headquarters: Pennsylvannia, USA

Ticker Symbol: CEPH (Nasdaq Stock Exchange) CP9 (Frankfurt Stock Exchange)

SEC Link: Cephalon

Subsidiaries:

Anesta

Arana Therapeutics

Cephalon Australia

Ception Therapeutics

ChemGenex

Gemin X Pharmaceuticals

Laboratoire Lafon

Mepha Pharma

Salmedix

Zeneus

Top 50 Pharma ranking*: 40

*Ranking based on reported global pharma sales for year ending December 2010.

Sales revenue (USD billions) [% change from 2009]: $2.8 [28.3%]

R&D spend (USD millions): $440

Top-selling drugs (USD billions): Provigil [1.1]

Partnering activity

View partnering activity: 2011,2010,2009,2008,2007,2006,2005

Full details on each deal can be found at CurrentAgreements (subscription required)

M&A activity

View M&A activity: 2011,2010,2009,2008,2007,2006,2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Available reports from Current Partnering:

Partnering Agreements with Cephalon

Partnering Agreements with Big Pharma, 3rd edition

Search all reports

Available resources providing deal coverage for Cephalon:

Current Agreements (subscription required)

Request a complimentary trial

Search Current Partnering for mention of Cephalon:

Search now

return to top 50 pharma list